Sign in or Register

Already a member?

Sign in

Or sign in with your account on:

Not a member yet?



Inovio Pharmaceuticals, Inc. (NYSE MKT: INO)

This text will be replaced


Dr. Joseph Kim discusses with Equities.com discuses the potential of synthetic vaccines and immune therapies for cancers and infectious diseases.

This video interview may include forward-looking statements that involve risks and uncertainties. Forward- looking statements are statements that are not historical facts and are subject to risks and uncertainties, which could cause actual results to differ from the forward-looking statements. To read our full disclosure, please go to: http://www.equities.com/disclaimer.
Back to Top

Popular Video

Cancer Genetics, Inc. (NASDAQ: CGIX) 

Lightbridge Corporation (NASDAQ: LTBR)

Newman & Morrison LLC

Cash Store Financial Services Inc.

Henry Weingarten

View all



blog comments powered by Disqus

 Today's Must Reads

Market Got You Down?: Here Are Six Hot Stocks

Global Winners and Losers in the Oil Shakeout

This Bull Market is No Stranger to Big Fourth-Quarter Comebacks

When to Sell and When to Rent an Investment Property

Saving the Small-Cap Market


Small-cap stocks offer investors many benefits, ranging from higher growth potential to overlooked value opportuni... in Equities.com's Hangs on LockerDome

About us

Equities.com is an advanced financial data portal and social network designed to connect self-directed investors with the world’s most innovative startup and small cap companies. Through our in-depth coverage of small cap markets, comprehensive research and stock valuation reports, state of the art issuer products, and world class events, Equities.com provides the social tools and insight that drive tomorrow’s investment relationships and opportunities.

Market Data powered by QuoteMedia.
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Terms of Use.

Login or Register